<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We measured circulating S100A8/A9 (MRP8/14) complex levels before and after 3-month treatment with <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> in type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed that <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> reduced circulating S100A8/A9 complex levels, without changing body mass index, in type 2 diabetic patients with abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>